1 | 40 mg QD Alogabat | - | - | - | - | 1件: 201 201 |
2 | 60 mg QD Alogabat | - | - | - | - | 1件: 201 201 |
3 | 7 mg QD Alogabat | - | - | - | - | 1件: 201 201 |
4 | Acylated and unacylated ghrelin dosages | 1件: Lenomorelin Lenomorelin | - | - | - | 3件: 193 193, 201, 202 |
5 | Aknemin | - | - | - | - | 1件: 201 201 |
6 | Aknemin 50 | - | - | - | - | 1件: 201 201 |
7 | Alogabat | - | - | - | - | 1件: 201 201 |
8 | Betaine | 1件: Betaine Betaine | 1件: D07523
D07523
| - | - | 2件: 201 201, 337 |
9 | CARBIDOPA | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 7件: 6 6, 13, 17, 90, 140, 164, 201 |
10 | Creatine | 1件: Creatine Creatine | - | - | - | 11件: 1 1, 2, 5, 6, 8, 46, 49, 50, 113, 156, 201 |
11 | Gaboxadol | 1件: Gaboxadol Gaboxadol | 1件: D04282
D04282
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 2件: 201 201, 206 |
12 | GABOXADOL MONOHYDRATE | 1件: Gaboxadol Gaboxadol | 1件: D04282
D04282
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 201 201 |
13 | Gaboxadol monohydrate 0.5 mg | 1件: Gaboxadol Gaboxadol | 1件: D04282
D04282
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 201 201 |
14 | Gaboxadol monohydrate 0.5 mg (intended commercial formulation) | 1件: Gaboxadol Gaboxadol | 1件: D04282
D04282
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 201 201 |
15 | Gaboxadol monohydrate 0.5 mg capsule | 1件: Gaboxadol Gaboxadol | 1件: D04282
D04282
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 201 201 |
16 | Gaboxadol monohydrate 2 mg | 1件: Gaboxadol Gaboxadol | 1件: D04282
D04282
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 201 201 |
17 | Gaboxadol monohydrate 2 mg (intended commercial formulation) | 1件: Gaboxadol Gaboxadol | 1件: D04282
D04282
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 201 201 |
18 | Gaboxadol monohydrate 2 mg capsule | 1件: Gaboxadol Gaboxadol | 1件: D04282
D04282
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 201 201 |
19 | Gaboxadol monohydrate 5 mg | 1件: Gaboxadol Gaboxadol | 1件: D04282
D04282
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 201 201 |
20 | Gaboxadol monohydrate 5 mg (intended commercial formulation) | 1件: Gaboxadol Gaboxadol | 1件: D04282
D04282
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 201 201 |
21 | Ghrelin | 1件: Lenomorelin Lenomorelin | - | - | - | 6件: 6 6, 78, 193, 201, 202, 299 |
22 | GTX-102 | 1件: GTX-102 GTX-102 | - | - | - | 2件: 65 65, 201 |
23 | ION582 | - | - | - | - | 1件: 201 201 |
24 | LEVODOPA | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 6件: 6 6, 17, 90, 140, 164, 201 |
25 | Levodopa/Carbidopa (4:1) | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 201 201 |
26 | Metafolin | - | - | - | - | 1件: 201 201 |
27 | Minocycline | 1件: Minocycline Minocycline | 1件: D05045
D05045
| - | - | 13件: 2 2, 6, 8, 13, 46, 85, 90, 94, 162, 201, 206, 280, 299 |
28 | Minocycline Hydrochloride | 1件: Minocycline Minocycline | 1件: D05045
D05045
| - | - | 4件: 13 13, 201, 206, 299 |
29 | NNZ-2591 | 1件: NNZ-2591 NNZ-2591 | - | - | - | 1件: 201 201 |
30 | Non disponibile | - | - | - | - | 1件: 201 201 |
31 | Nutritional Formulation Containing Exogenous Ketones | - | - | - | - | 1件: 201 201 |
32 | OV101 | - | - | - | - | 2件: 201 201, 206 |
33 | OV101 Regimen 1 | - | - | - | - | 1件: 201 201 |
34 | OV101 regimen 2 | - | - | - | - | 1件: 201 201 |
35 | Part 2 Adult Alogabat High Dose (aged 15-17) | - | - | - | - | 1件: 201 201 |
36 | RO7248824 | - | - | - | - | 1件: 201 201 |
37 | RO7248824/F02-01 | - | - | - | - | 1件: 201 201 |
38 | RO7248824/F03-01 (Diluent for RO7248824/F02-01 | - | - | - | - | 1件: 201 201 |
39 | Vitamin B12 | 1件: Cyanocobalamin Cyanocobalamin | 4件: D00166
D00166
,
D03615
,
D03616
,
D03617
| - | - | 4件: 6 6, 201, 229, 299 |